(Q34907270)

5 August 2017

title

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis (English)

1 reference

5 August 2017

author

Evangelos Cholongitas

1

object named as

Evangelos Cholongitas

1 reference

5 August 2017

10

Evangelos Akriviadis

1 reference

5 August 2017

author name string

George V Papatheodoridis

2

1 reference

5 August 2017

John Goulis

3

1 reference

5 August 2017

John Vlachogiannakos

4

1 reference

5 August 2017

Stylianos Karatapanis

5

1 reference

5 August 2017

John Ketikoglou

6

1 reference

5 August 2017

Themistoklis Vasiliadis

7

1 reference

5 August 2017

George Kontos

8

1 reference

5 August 2017

Anastasios Karlaftis

9

1 reference

5 August 2017

publication date

1 January 2015

1 reference

Annals of Gastroenterology

5 August 2017

published in

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

109-117

1 reference

De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Current management of hepatitis B virus infection before and after liver transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Model for end-stage liver disease (MELD) and allocation of donor livers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Hepatitis B: an important public health issue

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Transection of the oesophagus for bleeding oesophageal varices

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Risk Factors of Chronic Kidney Disease in HIV-infected Patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4289983

AASLD practice guidelines: Evaluation of the patient for liver transplantation

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25608681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25608681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25608681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

4289983

1 reference

5 August 2017

1 reference